What are the benefits and risks of fasting for therapeutic purposes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benefits and Risks of Therapeutic Fasting

Therapeutic fasting should be approached with caution as it carries significant health risks for certain populations, while offering potential benefits for specific conditions when properly supervised.

Types of Therapeutic Fasting

There are several approaches to therapeutic fasting:

  • Religious fasting (e.g., Ramadan): Fixed duration and timing with high intrinsic motivation 1
  • Intermittent fasting: Flexible duration and timing, including:
    • Time-restricted feeding (eating within a 6-8 hour window)
    • Alternate-day fasting
    • Periodic fasting (2-21 days) 2
  • Medically supervised modified fasting: 200-500 kcal/day for 7-21 days 3
  • Fasting mimicking diet: 800-1100 calories/day for 5 consecutive days 4

Potential Benefits

  1. Metabolic improvements:

    • Weight loss and improved insulin sensitivity 5
    • Decreased dyslipidemia and blood pressure 5
    • Beneficial for patients with non-alcoholic fatty liver disease (NAFLD) 1
  2. Chronic disease management:

    • Efficacious in treating rheumatic diseases, chronic pain syndromes, hypertension, and metabolic syndrome 3
    • May counteract disease processes in diabetes, cardiovascular disease, and neurological disorders 2
  3. Cellular mechanisms:

    • Activation of adaptive cellular stress response pathways 2
    • Enhanced mitochondrial health, DNA repair, and autophagy 2
    • Promotion of stem cell-based regeneration 2

Significant Risks and Contraindications

Fasting is contraindicated in:

  • Patients with acute hepatitis (regardless of cause or severity) 1
  • Child B and C cirrhosis 1, 4
  • Patients with peptic ulcers 1, 4
  • Malnutrition or risk of sarcopenia 1, 4
  • Decompensated liver disease 4
  • Cancer patients undergoing chemotherapy (outside clinical trials) 6
  • Patients with eating disorders 4

For patients with diabetes, fasting carries substantial risks:

  • Hypoglycemia (particularly with insulin or sulfonylureas) 1
  • Hyperglycemia and diabetic ketoacidosis 1
  • Dehydration and thrombosis 1

Risk Assessment and Monitoring

Before initiating therapeutic fasting:

  1. Medical screening:

    • Complete blood count
    • Comprehensive metabolic panel
    • Lipid profile
    • Blood pressure assessment
    • Body composition analysis 4
  2. Risk factor assessment:

    • History of eating disorders
    • Current nutritional status
    • Medication review 4
  3. During fasting:

    • Daily weight checks
    • Blood pressure monitoring
    • Blood glucose monitoring (for diabetic patients)
    • Minimum 2 liters fluid intake daily 4

Special Populations

  1. Patients with diabetes:

    • Require comprehensive risk assessment using the International Diabetes Federation and Diabetes and Ramadan International Alliance risk scoring system 1
    • Treatment plans must be optimized in advance 1
    • Consider continuous glucose monitoring to enhance safety 1
  2. Liver disease patients:

    • Child A post-hepatitic cirrhosis patients can fast with proper monitoring 1
    • Gilbert's syndrome patients can fast with regular bilirubin monitoring 1

Implementation Guidelines

For those who can safely fast:

  1. Modified fasting approach:

    • Consider intermittent fasting with 800-1100 calories/day as a less extreme approach 4
    • Medically supervised modified fasting (200-500 kcal/day for 7-21 days) for specific conditions 3
  2. Refeeding protocol:

    • Gradual refeeding after fasting is crucial to prevent complications 4
    • Focus on easily digestible foods initially 4
  3. Follow-up assessment:

    • Reassess weight, blood pressure, and metabolic markers 4
    • Evaluate need for continuation based on results 4

Conclusion

While therapeutic fasting shows promise for certain conditions, it must be approached with caution and medical supervision. The risks can be substantial for vulnerable populations, and benefits appear most pronounced for specific conditions like NAFLD, rheumatic diseases, and metabolic syndrome. More large-scale, long-term clinical trials are needed to fully establish the efficacy and safety of various fasting protocols.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fasting Guidelines for Medical Professionals

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Intermittent fasting in the prevention and treatment of cancer.

CA: a cancer journal for clinicians, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.